Exchange: NASDAQ·Updated 04:10 PM EDT
News
all
press releases
Core Thesis Behind Lifecore Biomedical (LFCR): Monetizing Excess Capacity
Core Thesis Behind Lifecore Biomedical (LFCR): Monetizing Excess Capacity...
Yahoo! Finance: News
More News
Lifecore Biomedical (LFCR) Q2 2026 Earnings Call Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets
Can Lifecore Biomedical, Inc. (LFCR) Unlock Long-Term Value Through Expanding Biopharma Collaborations?
Can Lifecore Biomedical, Inc. (LFCR) Unlock Long-Term Value Through Expanding Biopharma Collaborations...
Yahoo! Finance: News
Lifecore Biomedical (NASDAQ:LFCR) Posts Quarterly Earnings Results, Misses Expectations By $0.19 EPS
Lifecore Biomedical (NASDAQ:LFCR - Get Free Report) posted its earnings results on Wednesday. The company reported ($0.43) EPS for the quarter, missing analysts' consensus estimates of ($0.24) by ($0.19). Lifecore Biomedical had a negative return on equity of 1,211.09% and a negative net margin of...
MarketBeat
Lifecore Biomedical Q1 Earnings Call Highlights
Lifecore Biomedical (NASDAQ:LFCR) executives highlighted new commercial site transfer wins, continued cost reductions, and improving liquidity during the company's first-quarter 2026 earnings call...
MarketBeat
Lifecore Biomedical Q1 2026 Earnings Call Transcript
read more...
Benzinga
Lifecore Biomedical, Inc. (NASDAQ:LFCR) Given Average Recommendation of "Hold" by Brokerages
Lifecore Biomedical, Inc. (NASDAQ:LFCR - Get Free Report) has been assigned a consensus recommendation of 'Hold' from the five brokerages that are currently covering the company, Marketbeat.com...
MarketBeat
Lifecore Biomedical (NASDAQ:LFCR) Price Target Raised to $6.00
Barrington Research upped their target price on Lifecore Biomedical from $5.50 to $6.00 and gave the stock an "outperform" rating in a research note on Wednesday...
MarketBeat
Lifecore Biomedical (LFCR) to Release Earnings on Tuesday
Lifecore Biomedical (NASDAQ:LFCR) will be releasing earnings after the market closes on Tuesday, May 5. (View Earnings Report at...
MarketBeat
Lifecore Biomedical, Inc. (NASDAQ:LFCR) Receives Average Recommendation of "Hold" from Analysts
Shares of Lifecore Biomedical, Inc. (NASDAQ:LFCR - Get Free Report) have received a consensus recommendation of "Hold" from the five brokerages that are covering the firm, MarketBeat reports. One...
MarketBeat

Advertisement|Remove ads.